OnCore Biopharma, Inc. — Form D

OnCore Biopharma, Inc. of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-09-23. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2014-09-23
• Form: D
• Accession: 0001192482-14-000186
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $1.0M
• Investors: 1
• Date of first sale: 2014-09-08
• Revenue range: Decline to Disclose
• SEC file number: 021-225198

Issuer

• Name: OnCore Biopharma, Inc.
• CIK: 0001620295
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2012
• Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
• Phone: 215-489-4928

Officers, directors & promoters (8)

More

• CIK 1620295 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search